Ignet
Search (e.g., vaccine, IFNG): Help
About
Home
Introduction
Statistics
Programs
Dignet
Gene
GenePair
BioSummarAI
Help & Docs
Documents
Help
FAQs
Links
Acknowledge
Disclaimer
Contact Us
UM Logo

UMMS Logo

UMMS Logo

Gene Information

Gene symbol: VCL

Gene name: vinculin

HGNC ID: 12665

Related Genes

# Gene Symbol Number of hits
1 ACTC1 1 hits
2 ACTN4 1 hits
3 BCAR1 1 hits
4 CDH3 1 hits
5 CFL1 1 hits
6 FN1 1 hits
7 MYOC 1 hits
8 NEFH 1 hits
9 NPHS1 1 hits
10 NPHS2 1 hits
11 OPTN 1 hits
12 PRKCA 1 hits
13 PTK2 1 hits
14 PXN 1 hits
15 SDC4 1 hits
16 TNC 1 hits
17 VCAM1 1 hits
18 VIM 1 hits
19 WT1 1 hits

Related Sentences

# PMID Sentence
1 8074995 However, P-cadherin, plakoglobin and vinculin are the only markers detected in future glomerular cells.
2 9422981 The cytoplasmic focal adhesion proteins vinculin, talin, paxillin, p130CAS, and pp125FAK were detected, although vinculin appeared to be confined mainly to the mesangium.
3 11553524 CD2AP and p130Cas localize to different F-actin structures in podocytes.
4 11553524 Mice lacking the 80-kDa CD2-associated protein (CD2AP) develop progressive renal failure that starts soon after birth with proteinuria and foot process effacement by unknown mechanisms.
5 11553524 CD2AP has been identified and cloned independently by virtue of its interaction with the T cell protein CD2 and with the docking protein p130Cas.
6 11553524 In the present study we examined the localization of CD2AP and p130Cas in the mouse glomerulus and in cultured podocytes.
7 11553524 In glomeruli, CD2AP and p130Cas immunofluorescence were observed in podocytes, where they colocalized with F-actin in foot processes.
8 11553524 In cultured podocytes, p130Cas was enriched at sites of focal adhesions, where it colocalized like vinculin with F-actin at stress fiber ends.
9 11553524 The spot-shaped F-actin structures were also stained by antibodies against the actin nucleation Arp2/3 complex and cortactin, both contributing to dynamic actin assembly.
10 11553524 Moreover, CD2AP spots in cultured podocytes were in close spatial association with actinin-4, but not actinin-1.
11 11553524 Our results suggest that CD2AP and p130Cas, which both colocalize with F-actin in podocytes in situ, possess different functions.
12 11553524 Whereas p130Cas is found in focal adhesions, CD2AP seems to be involved in the regulation of highly dynamic F-actin structures in podocyte foot processes.
13 18855004 When compared to equal amounts of fibronectin or collagen 1, myocilin was less effective in promoting substrate adhesion.
14 18855004 Twenty-five percent of cells that had attached to myocilin substrates showed spreading and expressed focal contacts which were labeled by vinculin/phalloidin staining.
15 21380797 Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.
16 21380797 The MYH9 gene encodes a non-muscle myosin IIA heavy chain (NMMHC-IIA) expressed in podocytes.
17 21380797 We demonstrate in vitro that plasmapheresis effluent from our patient rapidly decreased cultured podocyte levels of the phosphorylated myosin light chain (MLC) that mediates NMMHC-IIA binding to actin and induced dispersion of NMMHC-IIA from its usual position along actin stress fibers.
18 21380797 FSGS plasma also caused dispersion of slit diaphragm proteins (nephrin and podocin) and vinculin-positive focal adhesion complexes.
19 21440751 For this purpose we evaluated the vinculin- and paxillin-containing adhesion complexes and α-smooth muscle actin (α-SMA) expression on tubular cells and glomerular podocytes in first year renal allograft biopsy specimens of 74 patients.
20 25096716 Furthermore, optineurin colocalizes with vinculin-labeled focal contacts of cultured podocytes and with lysosome-like structures.
21 26936875 Immunostaining of glomeruli from mice whose podocytes were null for Ndst1 (Ndst1(-/-)) showed a disrupted pattern of localization for the cell surface proteoglycan, syndecan-4, and for α-actinin-4 compared with controls.
22 26936875 The pattern of immunostaining for synaptopodin and nephrin did not show as significant alterations.
23 26936875 Immunostaining in vitro for several markers for molecules involved in cell-matrix interactions showed that Ndst1(-/-) cells had decreased clustering of syndecan-4 and decreased recruitment of protein kinase-Cα, α-actinin-4, vinculin, and phospho-focal adhesion kinase to focal adhesions.
24 30258943 The imPOD cells express most podocyte-related markers, including WT-1, Nephrin, Tubulin and Vinculin, but not differentiation marker Synaptopodin.
25 30258943 We further demonstrate that TGFβ1 induces a podocyte injury-like response in the FLP-reverted imPOD cells by suppressing the expression of slit diaphragm-associated proteins P-Cadherin and ZO-1 and upregulating the expression of mesenchymal markers, α-SMA, Vimentin and Nestin, as well as fibrogenic factors CTGF and Col1a1.
26 30464326 Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment.
27 30464326 Immunofluorescence and co-immunoprecipitation analyses revealed that NEFH was colocalized with synaptopodin, a podocyte-specific marker.
28 30464326 High NEFH expression in podocytes prevented the Adriamycin-induced reduction in synaptopodin expression.
29 30464326 The siRNA-mediated knockdown of NEFH in podocytes reduced the number of vinculin-containing focal contacts, thereby reducing adhesion to the extracellular matrix and increasing podocyte detachment.
30 30464326 These findings indicate that NEFH is expressed in podocytes during the disease course and that it prevents the reduction in synaptopodin expression and detachment of podocytes.
31 31675484 Furthermore, Fn1 KO podocytes showed a significant down-regulation of the focal adhesion proteins talin, vinculin, and paxillin and a reduced cell spreading, indicating an important role of Fn1 in adhesion.
32 33024228 Western blot and immunocytochemistry confirmed the alteration in the protein expression of tubulin, vimentin, podocin, cofilin-1, vinculin, E-cadherin, nephrin, VCAM-1, tenascin-C, and β-catenin.